Phillips-Medisize, a Molex company, announced today an agreement with a Global Pharmaceutical Company, where Phillips-Medisize acquired exclusive ownership of patents supporting an innovative mini-tablet dispenser to accommodate the varied and customized oral dispensing needs of patients.
“Through its unique working principle, the mini-tablet dispenser will be valuable in pediatrics, geriatrics and oncology where patients often require highly flexible oral dosing based on age, weight and other variables,” said Matt Jennings, CEO and President, Phillips-Medisize. “Furthermore, in smaller patient populations the option to flexibly count to combine incremental mini-tablet doses offers an advantage over preparing multiple fixed oral tablet dose strengths.”
The mini-tablet dispenser differentiates itself from most available systems that predominantly rely on volumetric measuring principles. With the assistance of this dispenser mounted on top of a standard tablet bottle, a patient or caregiver will be able to count and dispense mini-tablets in predetermined amounts from one to twenty tablets, and it supports tablets of approximately 2×2 mm to 2.3×2.3 mm dimensions. The mini-tablet dispenser enables the user to visually confirm the measured tablet count number before dispensing and is designed to minimize damage or crushing of the mini-tablets during dispensing.
Phillips-Medisize has begun industrialization preparations aiming to make the dispenser available to an array of pharmaceutical companies globally in early 2020.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Date: September 17, 2019
Source: Finance Yahoo
